Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia

Author： Habibi Darya  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.4, 2012-08, pp. : 1361-1370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminoacyl-tRNA Synthetase Inhibitors As Potent Antibacterials

By  

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3550-3563

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

By Taghdisi Seyed Mohammad   Abnous Khalil   Mosaffa Fatemeh   Behravan Javad  

Journal of Drug Targeting, Vol. 18, Iss. 4, 2010-05 ,pp. : 277-281

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia

By  

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatments in Acute Lymphoblastic Leukemia

By  

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 19-31

Bentham Science Publishers

Access to resources Recommend Favorite

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

By Sonpavde Guru   Hutson Thomas E   Sternberg Cora N  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 253-261

Informa Healthcare

Access to resources Recommend Favorite